BR100 Increased By (0.59%)
BR30 Increased By (0.78%)
KSE100 Increased By (0.4%)
KSE30 Increased By (0.43%)
BECO 6.09 Increased By ▲ 0.32 (5.55%)
BML 52.62 Decreased By ▼ -0.38 (-0.72%)
BOP 34.35 Increased By ▲ 0.36 (1.06%)
CNERGY 8.16 Increased By ▲ 0.05 (0.62%)
DCL 12.25 Increased By ▲ 0.05 (0.41%)
FCCL 53.30 Increased By ▲ 0.47 (0.89%)
FCSC 5.15 Increased By ▲ 0.08 (1.58%)
FFL 18.02 Increased By ▲ 0.07 (0.39%)
FNEL 1.32 Increased By ▲ 0.03 (2.33%)
HUMNL 10.86 Decreased By ▼ -0.02 (-0.18%)
KEL 8.15 Increased By ▲ 0.13 (1.62%)
KOSM 5.29 Decreased By ▼ -0.23 (-4.17%)
MLCF 87.05 Increased By ▲ 0.54 (0.62%)
NBP 187.10 Increased By ▲ 1.94 (1.05%)
PACE 10.62 Increased By ▲ 0.04 (0.38%)
PAEL 39.90 Increased By ▲ 0.48 (1.22%)
PIAHCLA 26.11 Decreased By ▼ -0.11 (-0.42%)
PIBTL 17.27 Increased By ▲ 0.60 (3.6%)
PPL 229.30 Increased By ▲ 1.12 (0.49%)
PRL 34.65 Decreased By ▼ -0.03 (-0.09%)
PTC 66.90 Increased By ▲ 1.57 (2.4%)
SEARL 90.63 Increased By ▲ 0.50 (0.55%)
SSGC 26.97 Increased By ▲ 0.37 (1.39%)
TELE 8.55 Increased By ▲ 0.27 (3.26%)
THCCL 58.41 Decreased By ▼ -0.09 (-0.15%)
TPLP 8.64 Increased By ▲ 0.42 (5.11%)
TREET 24.55 Increased By ▲ 0.02 (0.08%)
TRG 69.74 Increased By ▲ 0.03 (0.04%)
WAVES 9.99 Increased By ▲ 0.05 (0.5%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
By

LONDON: Revenue at Europe’s largest companies is expected to have risen by just 0.9% in the fourth quarter, Refinitiv I/B/E/S data showed on Tuesday, down from 27.4% in the third quarter and the slowest growth rate since the fourth quarter of 2020.

Earnings for STOXX 600 companies are expected to have increased 9.5% in the fourth quarter, down from 10.7% a week ago, Refinitiv I/B/E/S said.

When results from the energy sector are excluded, Refinitiv I/B/E/S said earnings were expected to have increased by 4.6% and revenue by just 0.3% in the final three months of the year.

Europe’s earnings season kicks into gear next week, with 56 companies expected to announce their fourth quarter results, including Italian bank UniCredit, Irish airline Ryanair, and pharmaceutical companies GSK and Novartis.

Analysts said the upcoming earnings season will likely show whether the renewed optimism about the economy that has buoyed equities in recent weeks is grounded in reality. To date, eight companies in the benchmark index have reported earnings, with 25% exceeding analysts estimates, versus a typical quarter, when 53% beat estimates, Refinitiv I/B/E/S said.

Nine firms have reported revenue, with 77.8 percent beating expectations, compared to a typical quarter when 58 percent beat estimates.

Comments

Comments are closed for this article.